Effect of Dapagliflozin on Glycemic Variability

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

May 31, 2017

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Dapagliflozin

DRUG

Placebo

Trial Locations (1)

Unknown

Seoul St.Mary's Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Severance Hospital

OTHER

collaborator

Eulji General Hospital

OTHER

collaborator

Kyung Hee University Hospital at Gangdong

OTHER

lead

The Catholic University of Korea

OTHER